What is Vicore Pharma Holding AB American Depositary Shares?
Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company develops Buloxibutid (C21), an orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) that is in Phase II clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF), as well as in Phase I clinical trial for treating pulmonary hypertension. The company is listed on the US in USA, operating in the Healthcare sector, with a market capitalisation of 291.78M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.